dark side of glp-1 meds no one talks about... 😬, #podcast #glp1 #health | Steven Bartlett Surgeon ALERT: The Dark Side

The platform offers evidence-based guidance for navigating metabolic peptide applications

It also exerts varying effects on the same virus depending on the type of infected cell

Both oral BPC-157 and injectable BPC-157 are available through PeptidesThailand.com under doctor supervision

45 ZhuY.ScheibingerM.EllwangerD

In the presence of 5.5 mM glucose, GLP- 1-mediated increments of [Ca 2+ ] i were reduced to approximately 20% after pre-treatment with 1 mM metformin (p 100 M metformin blocked this effect in the presence of 5.5 mM glucose, no effect of metformin was observed in the presence of 16.7 mM glucose (Figure 3(a))